Merck & Co. Other current assets increased by 1.0% to $10.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.4%, from $9.29B to $10.62B. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 17.6% CAGR.
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Standard across all industries; usually a minor component of the balance sheet.
current_assets_other_assets_current| Q4 '21 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.99B | $7.17B | $6.66B | $8.37B | $7.95B | $8.74B | $8.14B | $8.71B | $9.29B | $10.00B | $10.78B | $10.52B | $10.62B |
| QoQ Change | — | +2.6% | -7.2% | +25.7% | -5.0% | +9.9% | -6.8% | +6.9% | +6.7% | +7.6% | +7.8% | -2.4% | +1.0% |
| YoY Change | — | +2.6% | — | +16.7% | — | — | +22.3% | +4.0% | +16.8% | +14.4% | +32.4% | +20.8% | +14.4% |